Advertisement
  • Contacts

    Rachel Savage
    Sr. Director of Marketing
    770-651-9194 | email
    Cynthia Dubose
    Digital Marketing Manager
    (770) 651-9286 | email
  • Product and Service Categories

  • MiMedx Group, Inc.

    1775 W. Oak Commons St., Marietta, Georgia 30062

    About Us

    MiMedx® is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare. “Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies are AmnioFix®, EpiFix®, EpiCord®, AmnioCord®, and AmnioFill®.  They are processed from human amniotic membrane derived from donated placentas. Elected in advance of delivery through our donor program, a mother delivering a healthy baby via scheduled full-term Caesarean section birth may donate the placenta in lieu of having it discarded as medical waste. To date, over 40 clinical and scientific papers have been published in peer-reviewed journals on our amniotic tissue-based technologies. MiMedx is the leading supplier of amniotic tissue, having supplied over 1,000,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare. 

    EpiFix® and AmnioFix® are bioactive tissue matrices composed of dehydrated Human Amnion/Chorion Membrane (dHACM) that preserve and contain essential regulatory proteins. EpiFix and AmnioFix are intended for homologous use in the treatment of acute and chronic wounds to provide a barrier, modulate inflammation, enhance healing, and reduce scar tissue formation.

    EpiCord® and AmnioCord® are dehydrated, non-viable cellular human umbilical cord allografts intended for homologous use. EpiCord and AmnioCord contain essential regulatory proteins and provide a protective environment for the healing process. 

    AmnioFill® is a placental connective tissue matrix allograft that may be used to replace or supplement damaged or inadequate integumental tissue and enhance healing. 

    EpiFix, AmnioFix, AmnioCord and AmnioFIll are processed using the PURION® Process, a unique approach that provides easy to use allografts that may be stored at ambient conditions. 

    Product Information

    EpiFix® and AmnioFix® are bioactive tissue matrices composed of dehydrated Human Amnion/Chorion Membrane (dHACM) that preserve and contain essential regulatory proteins. EpiFix and AmnioFix are intended for homologous use in the treatment of acute and chronic wounds to provide a barrier, modulate inflammation, enhance healing, and reduce scar tissue formation. 
    Learn More